BioCentury
ARTICLE | Clinical News

Actimmune interferon gamma-1b: Phase I started

January 4, 2016 8:00 AM UTC

Horizon began an open-label, U.S. Phase I trial to evaluate subcutaneous Actimmune every other day in combination with IV Opdivo nivolumab in patients with advanced solid tumors who have progressed o...